Doxophos Vet Clause Samples

Doxophos Vet. Doxophos Vet is a preparation consisting of the Compounds and XR17 (including all salts of XR17) for the treatment of cancer with the active pharmaceutical ingredient doxorubicin. XR17 is a proprietary mixture of the sodium salts of N-all-trans-retinoyl cysteic acid methyl ester and N-13-cis-retinoyl cysteic acid methyl ester. The product can be in the form of a water soluble lyophilisate or as a solution for injection. The Compounds can be of natural, semi-synthetic or synthetic origin. Product shall be Doxophos Vet in final sellable form, furnished hereunder in the packaging and with the materials set forth below at no additional cost: